These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7913235)

  • 21. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
    Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
    Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychophysiological differences in schizophrenics with and without delusional misidentification syndromes: a P300 study.
    Papageorgiou C; Lykouras L; Alevizos B; Ventouras E; Mourtzouchou P; Uzunoglu N; Christodoulou GN; Rabavilas A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):593-601. PubMed ID: 15866363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N400 abnormalities in late life schizophrenia and related psychoses.
    Olichney JM; Iragui VJ; Kutas M; Nowacki R; Jeste DV
    Biol Psychiatry; 1997 Jul; 42(1):13-23. PubMed ID: 9193737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients.
    Adler G; Markert U; Gattaz WF
    Pharmacopsychiatry; 1994 Mar; 27(2):68-9. PubMed ID: 7913236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities of auditory event-related potentials in schizophrenia prior to treatment.
    Hirayasu Y; Asato N; Ohta H; Hokama H; Arakaki H; Ogura C
    Biol Psychiatry; 1998 Feb; 43(4):244-53. PubMed ID: 9513733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between residual symptomatology and auditory evoked potentials in schizophrenic outpatients.
    Hegerl U; Gaebel W; Ulrich G
    Pharmacopsychiatry; 1988 Nov; 21(6):329-30. PubMed ID: 2907638
    [No Abstract]   [Full Text] [Related]  

  • 31. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.
    Davatzikos C; Shen D; Gur RC; Wu X; Liu D; Fan Y; Hughett P; Turetsky BI; Gur RE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1218-27. PubMed ID: 16275809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First month of neuroleptic treatment in schizophrenia: only partial normalization of the late positive components of visual ERP.
    Mintz M; Hermesh H; Glicksohn J; Munitz H; Radwan M
    Biol Psychiatry; 1995 Mar; 37(6):402-9. PubMed ID: 7772649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology.
    Turetsky BI; Colbath EA; Gur RE
    Biol Psychiatry; 1998 Jan; 43(2):84-96. PubMed ID: 9474441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimensional complexity of EEG brain mechanisms in untreated schizophrenia.
    Koukkou M; Lehmann D; Wackermann J; Dvorak I; Henggeler B
    Biol Psychiatry; 1993 Mar; 33(6):397-407. PubMed ID: 8098223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative symptoms in schizophrenia.
    Boutros NN; Mucci A; Diwadkar V; Tandon R
    Clin Schizophr Relat Psychoses; 2014 Apr; 8(1):28-35B. PubMed ID: 23428787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristic distribution of alpha 2 wave in electroencephalograms of schizophrenic patients during discriminative tasks: support for the hypofrontality hypothesis of schizophrenia.
    Nakagawa M; Takeda K; Kakimoto Y
    Acta Psychiatr Scand; 1991 Feb; 83(2):105-14. PubMed ID: 1673281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms.
    Pfefferbaum A; Ford JM; White PM; Roth WT
    Arch Gen Psychiatry; 1989 Nov; 46(11):1035-44. PubMed ID: 2573328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evoked gamma band synchronization and the liability for schizophrenia.
    Hong LE; Summerfelt A; McMahon R; Adami H; Francis G; Elliott A; Buchanan RW; Thaker GK
    Schizophr Res; 2004 Oct; 70(2-3):293-302. PubMed ID: 15329305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central serotonergic function in patients with predominantly negative symptoms of schizophrenia.
    Uhl I; Kulik A; Roser P; Theodoridou A; Wyss C; Norra C; Brüne M; Kawohl W; Juckel G
    Schizophr Res; 2018 Mar; 193():443-444. PubMed ID: 28641887
    [No Abstract]   [Full Text] [Related]  

  • 40. Recording automatic and controlled information processing by means of bioelectrical brain signals in normals and paranoid schizophrenics with and without neuroleptic medication.
    Krieger S; Bertling R; Schweizer A; Tegeler J
    Pharmacopsychiatry; 1988 Nov; 21(6):331-3. PubMed ID: 2907639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.